Operating Expenses: The sum of all operating expenses for the given industry.
Galera Therapeutics, Inc. (GRTX) had Operating Expenses of $1.44M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-1.39M |
|
-- |
|
-- |
|
|
Operating Expenses |
$1.44M |
$-1.44M |
|
$0.05M |
|
$-1.39M |
|
$-1.39M |
|
$-1.39M |
|
$-1.39M |
|
$-1.39M |
|
$-1.39M |
|
$-1.44M |
|
$-1.44M |
|
98.50M |
|
98.50M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$4.90M |
|
-- |
|
$0.10M |
|
$5.00M |
|
$0.60M |
|
-- |
|
$151.05M |
|
$151.65M |
|
$-149.22M |
|
$-146.65M |
|
$-146.65M |
|
75.46M |
|
| Cash Flow Statement Financials | |
$-4.45M |
|
-- |
|
$0.64M |
|
$8.29M |
|
$4.47M |
|
$-3.82M |
|
$0.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.20 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.45M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
0.93% |
|
0.95% |
|
-27.75% |
|
0.95% |
|
$-1.94 |
|
$-0.05 |
|
$-0.05 |
|